Targeted NGS Panels

Streamlined, Robust and Economical NGS Enrichment

Current methods of targeted next-generation sequencing (NGS) enrichment are complicated, labor-intensive and can take days to accomplish. In addition, samples commonly fail analysis due to insufficient amounts of nucleic acid (the dreaded "DNA Not Sufficient" or "DNS" situation) or incomplete coverage of target regions will miss important variant calls. With increasing costs of labor and time to re-run precious samples, you do not have the luxury of an inefficient clinical laboratory process.

Pillar Biosciences addresses these challenges with our streamlined SLIMamp technology, offering clinical NGS panels that are simple to implement, robust in its sensitivity and specificity, and economical.